1. Angiogenesis Inhibitors
Supplementary Figure 1 A
Supplementary Figure 2 A B
Angiogenesis Inhibitors
EpI Screen

2. SKOV3 DMSO Vorinostat Mocetinostat Entinostat 500 nM 5 mM
Supplementary Figure 3
SKOV3
DMSO
Vorinostat
Mocetinostat
Entinostat
2.7
5.7
6.1
4.7
500 nM
1.0
1.7
4.1
3.1
92.1
87.5
85.6
87.2
5.0
11.2
12.7
8.3
5 mM
0.7
7.3
11.3
6.9
88.5
74.8
71.3
79.1

3. T24 DMSO Vorinostat Mocetinostat Entinostat 500 nM 5 mM
Supplementary Figure 3 (cont’d)
T24
DMSO
Vorinostat
Mocetinostat
Entinostat
10.2
9.9
23.3
18.6
500 nM
2.6
2.8
8.1
4.7
83.0
80.9
65.0
71.3
6.6
15.8
16.0
12.7
5 mM
1.6
11.0
33.5
14.5
85.8
68.8
48.2
68.5

4. Supplementary Figure 4 A B C 24 96 (Hr) DMSO or HDACi Treatment24 96
(Hr)
DMSO or
HDACi
Treatment
Cell Plating
MTS Assay 48
Taxol B C